from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0535/pnp

LFCtreatmentdescriptionclass of inhibitor

0.032

Amikacinug/mL Amikacintranslation

-1.088

Cap5-10ug/mL Capreomycintranslation

0.032

Rox10-50 ug/mL Roxithromycintranslation

-0.629

SM2-5 ug/mL Streptomycintranslation

0.111

Tet5-10 ug/mL Tetracyclinetranslation

-2.127

Rif0.2-5ug/mL Rifampicintranscription

-0.551

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.808

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.491

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.387

CPZ10-50 ug/mL Chlorpromazinerespiration

1.549

Clofazimine10-13 ug/mL Clofaziminerespiration

0.468

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.514

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.703

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.057

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.365

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.346

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.177

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.287

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.220

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.372

KCN5-20 ug/mL Potassium cyaniderespiration

0.184

NaN30.2-2 mM Sodium aziderespiration

-0.336

Nigericin50 uM Nigericinrespiration

-0.843

TRC10-150 ug/mL Triclosanrespiration

1.202

TRZ10-25 ug/mL Thioridazinerespiration

1.319

Valinomycin0.5-10 uM Valinomycinrespiration

0.284

ZnSO42 mM ZnSO4respiration

-0.184

menadione6-10 ug/mL Menadionerespiration

0.069

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.593

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.104

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.656

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.253

NRP_1Non-replicating persistence stage 1dosRassociated

-0.418

Amp0.2mg/mL AmpicillincellWall

0.422

Cephalexin20-100 ug/mL CephalexincellWall

-0.783

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.115

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.010

EMB10-20 ug/mL EthambutolcellWall

-0.546

Eta12-40 ug/mL EthionamidecellWall

0.031

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.833

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.144

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.304

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.268

BZA0.12 mg/mL BenzamidearomaticAmides

-0.078

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.620

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.587

H2O24 mM hydrogen peroxideDNAdamaging

-0.557

Levo10 ug/mL LevofloxacinDNAdamaging

0.092

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.835

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.461

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.949

UVUV-irradiationDNAdamaging

0.500

ARP41-4 ug/mL Antitubercular compound ARP4?

0.354

Antimycin12.5-50 ug/mL Antimycin A?

0.422

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.649

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.029

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.110

PA8240.2-2 ug/mL PA-824?

0.440

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.328

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.710

Verapamil50 uM Verapamil?

0.778

mercaptoethanol2 mM 2-Mercaptoethanol?

1.164

methoxatin10-20 ug/mL Methoxatin?